Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

A.C. Kroksveen; J.D. Jaffe; E. Aasebo; H. Barsnes; Y. Bjorlykke; D. Franciotta; H. Keshishian; K.M. Myhr; J.A. Opsahl; V. van Pesch; C.E. Teunissen; O. Torkildsen; R.J. Ulvik; H. Vethe; S.A. Carr; F.S. Berven

doi:10.1002/pmic.201400142

Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

A.C. Kroksveen, J.D. Jaffe, E. Aasebo, H. Barsnes, Y. Bjorlykke, D. Franciotta, H. Keshishian, K.M. Myhr, J.A. Opsahl, V. van Pesch, C.E. Teunissen, O. Torkildsen, R.J. Ulvik, H. Vethe, S.A. Carr, F.S. Berven

Clinical chemistry

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	3361-3369
Journal	Proteomics
Volume	15
Issue number	19
DOIs	https://doi.org/10.1002/pmic.201400142
Publication status	Published - 2015

Access to Document

10.1002/pmic.201400142

Cite this

Kroksveen, A. C., Jaffe, J. D., Aasebo, E., Barsnes, H., Bjorlykke, Y., Franciotta, D., Keshishian, H., Myhr, K. M., Opsahl, J. A., van Pesch, V., Teunissen, C. E., Torkildsen, O., Ulvik, R. J., Vethe, H., Carr, S. A., & Berven, F. S. (2015). Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics, 15(19), 3361-3369. https://doi.org/10.1002/pmic.201400142

Kroksveen, A.C. ; Jaffe, J.D. ; Aasebo, E. ; Barsnes, H. ; Bjorlykke, Y. ; Franciotta, D. ; Keshishian, H. ; Myhr, K.M. ; Opsahl, J.A. ; van Pesch, V. ; Teunissen, C.E. ; Torkildsen, O. ; Ulvik, R.J. ; Vethe, H. ; Carr, S.A. ; Berven, F.S. / Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. In: Proteomics. 2015 ; Vol. 15, No. 19. pp. 3361-3369.

@article{4c5cd84b5e4841b2ae0c06101c864d19,

title = "Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis",

author = "A.C. Kroksveen and J.D. Jaffe and E. Aasebo and H. Barsnes and Y. Bjorlykke and D. Franciotta and H. Keshishian and K.M. Myhr and J.A. Opsahl and {van Pesch}, V. and C.E. Teunissen and O. Torkildsen and R.J. Ulvik and H. Vethe and S.A. Carr and F.S. Berven",

year = "2015",

doi = "10.1002/pmic.201400142",

language = "Undefined/Unknown",

volume = "15",

pages = "3361--3369",

journal = "Proteomics",

issn = "1615-9853",

publisher = "Wiley-VCH Verlag",

number = "19",

}

Kroksveen, AC, Jaffe, JD, Aasebo, E, Barsnes, H, Bjorlykke, Y, Franciotta, D, Keshishian, H, Myhr, KM, Opsahl, JA, van Pesch, V, Teunissen, CE, Torkildsen, O, Ulvik, RJ, Vethe, H, Carr, SA & Berven, FS 2015, 'Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis', Proteomics, vol. 15, no. 19, pp. 3361-3369. https://doi.org/10.1002/pmic.201400142

Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. / Kroksveen, A.C.; Jaffe, J.D.; Aasebo, E.; Barsnes, H.; Bjorlykke, Y.; Franciotta, D.; Keshishian, H.; Myhr, K.M.; Opsahl, J.A.; van Pesch, V.; Teunissen, C.E.; Torkildsen, O.; Ulvik, R.J.; Vethe, H.; Carr, S.A.; Berven, F.S.

In: Proteomics, Vol. 15, No. 19, 2015, p. 3361-3369.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

AU - Kroksveen, A.C.

AU - Jaffe, J.D.

AU - Aasebo, E.

AU - Barsnes, H.

AU - Bjorlykke, Y.

AU - Franciotta, D.

AU - Keshishian, H.

AU - Myhr, K.M.

AU - Opsahl, J.A.

AU - van Pesch, V.

AU - Teunissen, C.E.

AU - Torkildsen, O.

AU - Ulvik, R.J.

AU - Vethe, H.

AU - Carr, S.A.

AU - Berven, F.S.

PY - 2015

Y1 - 2015

U2 - 10.1002/pmic.201400142

DO - 10.1002/pmic.201400142

M3 - Article

C2 - 26152395

VL - 15

SP - 3361

EP - 3369

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 19

ER -